Press Releases
Stay up to date with press releases covering announcements, company news, product launches, and business updates.
Publish your press release
Public Health Command Europe Hosts 71st International Military Veterinary Exchange
DVIDS - Georgia
Garmisch- Partenkirchen, Germany --- Public Health Command Europe recently hosted the 71st International Military Veterinary Exchange, bringing together nearly 100 veterinary leaders from 18 Allied and Partner nations to strengthen alliances,...
ABL Diagnostics Secures New Global Tenders and Continues to Expand Distribution Network
EIN Presswire
ABL Diagnostics accelerates international growth with key public contracts and platform-agnostic microbiology solutions across EMEA, Asia, and the US. WOIPPY, FRANCE, May 27, 2026 /EINPresswire.com/ -- ABL Diagnostics (FR001400AHX6 – “ABLD”), a...
New REDUCE-IT® Analysis Presented at the European Atherosclerosis Society (EAS) Congress 2026 Suggests Risk-Weighted ApoB May Improve Identification of Residual Cardiovascular Risk in Statin-Treated Patients with Hypertriglyceridemia
GlobeNewswire, Inc.
DUBLIN and BRIDGEWATER, N.J., May 27, 2026 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ: AMRN) (Amarin), a company committed to advancing the science of cardiovascular disease (CVD) worldwide, today announced new data from a post hoc...
Revieve and Matas Group Forge a Nordic-Wide Partnership to Scale AI-Powered Beauty Across the Nordics
EIN Presswire
Matas Group partners with Revieve to deliver AI-powered beauty experiences across Matas and KICKS, supporting the Group’s ambition to win the Nordics.
Orion Pharma to present its first clinical data from Phase 1/2 TEADES trial of TEAD inhibitor ODM-212 at the 2026 ASCO® Annual Meeting
GlobeNewswire, Inc.
ORION CORPORATION PRESS RELEASE 21 MAY 2026 at 10:30 EEST Orion Pharma to present its first clinical data from Phase 1/2 TEADES trial of TEAD inhibitor ODM-212 at the 2026 ASCO® Annual Meeting First clinical data from the Phase 1/2 TEADES trial of...
Resmed and ŌURA Partner to Expand Access to Sleep Health Education and Care
GlobeNewswire, Inc.
SAN DIEGO, May 19, 2026 (GLOBE NEWSWIRE) -- Resmed (NYSE: RMD, ASX: RMD), the leading health technology company focused on sleep, breathing and care delivered in the home, and ŌURA, maker of the world’s leading smart ring, today announced they are...
Herantis Pharma partners with Indivi to enable detection of early treatment effects in upcoming HER-096 Phase 2 trial in Parkinson’s disease
GlobeNewswire, Inc.
Herantis Pharma Plc – Press release Indivi’s digital biomarker platform is designed to enable earlier and more sensitive detection of treatment-related changes Improved sensitivity and reduced variability may support more efficient clinical...
Finland Classifies Andes Hantavirus as Public Health Risk
MENAFN
(MENAFN) Finland has officially designated the Andes strain of hantavirus a "public health risk" following reports of possible exposure within the country, a public broadcaster reported Tuesday — a classification that unlocks compensation for...
Silexion Therapeutics Announces Initiation of GMP Clinical Supply Manufacturing of SIL204 with Leading Global CDMO, and New Approval of Phase 2/3 Trial From Tel Aviv Sourasky Medical Center
GlobeNewswire, Inc.
Silexion advances toward Phase 2/3 trial in KRAS-driven pancreatic cancer, as SIL204 begins GMP clinical manufacturing in collaboration with global leading manufacturing partner Catalent at its European center of excellence Tel Aviv Sourasky...
Orion Animal Health receives US FDA approval for Tessie® (tasipimidine oral solution) for the treatment of noise aversion and separation anxiety in dogs
GlobeNewswire, Inc.
ORION CORPORATION PRESS RELEASE 12 MAY 2026 at 10:30 EEST Orion Animal Health receives US FDA approval for Tessie® (tasipimidine oral solution) for the treatment of noise aversion and separation anxiety in dogs Orion Corporation today announced...
Financial Stability Review, May 2026
ECB - European Central Bank
At the turn of the year 2025-26, economic growth surprised on the upside while financial market sentiment remained strong despite high uncertainty.
Gaza: Red Cross Field Hospital in Rafah undergoes overhaul to continue addressing urgent health care needs
International Committee of the Red Cross
“The entry of medical equipment and supplies for the Red Cross Field Hospital is a positive step towards responding to the medical needs of people in Gaza,” said Julien Lerisson, the ICRC’s head of delegation in Israel and the Occupied...
Finland Causations of Increasing Strain on Country’s Public Finances
MENAFN
(MENAFN) Finland’s finance minister Riikka Purra has raised concerns about increasing strain on the country’s public finances, shortly after the government introduced a long-term fiscal plan that pairs higher military assistance to Ukraine with...
Two years on: upgrading the Red Cross Field Hospital in Rafah
International Committee of the Red Cross
Over the last two years, the Red Cross Field Hospital has been a constant in Gaza's fractured health landscape.
Thai University Approves Helsinki-Standard Study of Maha Taksa Astrology Tradition
EIN Presswire
Mae Fah Luang University's Human Research Ethics Committee has approved a qualitative study of Maha Taksa, the Thai astrology system, under Helsinki standards.
Gluten-Free Products Market Gaining Momentum with Health-Driven Consumer Trends
GlobeNewswire, Inc.
Delray Beach, FL, April 30, 2026 (GLOBE NEWSWIRE) -- The global gluten-free products market is experiencing steady expansion as consumers increasingly shift toward healthier and more personalized dietary choices.
Orion Pharma initiates TEADCO Phase 1b/2 basket trial evaluating ODM-212 in combination with standard of care treatments in patients with select advanced solid tumours
GlobeNewswire, Inc.
ORION CORPORATION PRESS RELEASE 23 APRIL 2026 at 09.00 EEST Orion Pharma initiates TEADCO Phase 1b/2 basket trial evaluating ODM-212 in combination with standard of care treatments in patients with select advanced solid tumours Orion Corporation...
Orion Pharma’s ODM-212 Granted Orphan Drug Designation in Mesothelioma by the US FDA
GlobeNewswire, Inc.
ORION CORPORATION PRESS RELEASE 20 APRIL 2026 at 16.00 EEST Orion Pharma’s ODM-212 Granted Orphan Drug Designation in Mesothelioma by the US FDA Orion Corporation (Orion Pharma) today announced that its investigational drug ODM-212 has received...
Finnish MP Gets Convicted for Pamphlet Deemed Offensive to Gay People
MENAFN
(MENAFN) Reports indicate that Finland’s Supreme Court has found Christian Democrat MP and former cabinet minister Paivi Rasanen guilty of “insulting homosexuals” over a church pamphlet published in 2004, in which she described same-sex...
Nanox Announces Collaboration with Meir Medical Center to Deploy Nanox.ARC for Orthopedic Imaging Clinical Study
GlobeNewswire, Inc.
Enhancing emergency triage imaging with Nanox.ARC to improve efficiency and lower radiation dose Collaboration expands clinical evidence base of Nanox.ARC to support broader adoption PETACH TIKVA, Israel, April 14, 2026 (GLOBE NEWSWIRE) -- Nanox...
Sign up for:
Health Daily Finland
The daily local news briefing you can trust. Every day. Subscribe now.
Check Your Email!
We sent a one-time activation link to: .
Confirm it's you by clicking the email link.
If the email is not in your inbox, check spam or try again.
Welcome back!
is already signed up. Check your inbox for updates.